Search
Guardant Health Inc
GHAdd to Watchlist
161.990USD
+9.640+6.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
20.25BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Guardant Health Inc is 8.75, ranking 18 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 100.00, with a high of 130.00 and a low of 48.21.
Analyst Rating
Based on
27
analysts
Buy
Current Rating
169.100
Target Price
+17.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Guardant Health Inc
GH
27
Medtronic PLC
MDT
33
Zimmer Biomet Holdings Inc
ZBH
31
Dexcom Inc
DXCM
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Guardant Health Inc's expected revenue for the next quarter?
Guardant Health Inc's expected revenue is 344.77M.
What is Guardant Health Inc's price target?
Analysts forecast that Guardant Health Inc's price target is USD 100.00, with the highest forecast at USD 130.00 and the lowest forecast at USD 48.21.
How have Guardant Health IncGH's recent earnings per share performed?
The market expectation was USD -0.90, while Guardant Health IncGH's earnings per share (EPS) for the previous quarter was USD -0.85. EPS for the next quarter is expected at USD -0.32.
What is the analyst rating for Guardant Health Inc?
Based on the ratings of Guardant Health Inc's stock from 27 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.